Beta Bionics Chief Commercial Officer Mark Hopman disposes of 36,870 common shares worth $680,723.44

• Beta Bionics Chief Commercial Officer Mark Hopman sold 36,870 common shares on Sep. 9, 2026 at USD 18.46.
• Post-transaction stake stood at 87,157 shares, held directly.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Beta Bionics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002048497-26-000013), on September 10, 2026, and is solely responsible for the information contained therein.